Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 330

1.

Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.

Hedrington MS, Davis SN.

Expert Opin Pharmacother. 2019 Oct 8:1-7. doi: 10.1080/14656566.2019.1672660. [Epub ahead of print]

PMID:
31593486
2.

Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition.

Rahman N, Muhammad I; Gul-E-Nayab, Khan H, Aschner M, Filosa R, Daglia M.

Biomolecules. 2019 Sep 27;9(10). pii: E544. doi: 10.3390/biom9100544.

3.

Diet-Induced Obese Mice and Leptin-Deficient Lepob/ob Mice Exhibit Increased Circulating GIP Levels Produced by Different Mechanisms.

Lee E, Miedzybrodzka EL, Zhang X, Hatano R, Miyamoto J, Kimura I, Fujimoto K, Uematsu S, Rodriguez-Cuenca S, Vidal-Puig A, Gribble FM, Reimann F, Miki T.

Int J Mol Sci. 2019 Sep 10;20(18). pii: E4448. doi: 10.3390/ijms20184448.

4.

Iminosugars: Effects of Stereochemistry, Ring Size, and N-Substituents on Glucosidase Activities.

Zamoner LOB, Aragão-Leoneti V, Carvalho I.

Pharmaceuticals (Basel). 2019 Jul 12;12(3). pii: E108. doi: 10.3390/ph12030108.

5.

Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.

Dhameja M, Gupta P.

Eur J Med Chem. 2019 Aug 15;176:343-377. doi: 10.1016/j.ejmech.2019.04.025. Epub 2019 Apr 30. Review.

PMID:
31112894
6.

Selective synthesis of 3-deoxy-5-hydroxy-1-amino-carbasugars as potential α-glucosidase inhibitors.

Jiang C, Liu Q, Liu J, Liu K, Tian L, Duan M, Wang Y, Shen Z, Xu Y.

Org Biomol Chem. 2019 May 29;17(21):5381-5391. doi: 10.1039/c9ob00762h.

PMID:
31107491
7.

Synergistic improvement of PQQ-dependent D-sorbitol dehydrogenase activity from Gluconobacter oxydans for the biosynthesis of miglitol precursor 6-(N-hydroxyethyl)-amino-6-deoxy-α-L-sorbofuranose.

Ke X, Pan-Hong Y, Hu ZC, Chen L, Sun XQ, Zheng YG.

J Biotechnol. 2019 Jul 20;300:55-62. doi: 10.1016/j.jbiotec.2019.05.007. Epub 2019 May 14.

PMID:
31100333
8.

Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones.

Aoki K, Sato H, Terauchi Y.

Endocr J. 2019 May 28;66(5):395-401. doi: 10.1507/endocrj.EJ19-0041. Epub 2019 Apr 23.

9.

Use of a deoxynojirimycin-fluorophore conjugate as a cell-specific imaging probe targeting α-glucosidase on cell membranes.

Hatano A, Kanno Y, Kondo Y, Sunaga Y, Umezawa H, Fukui K.

Bioorg Med Chem. 2019 Mar 1;27(5):859-864. doi: 10.1016/j.bmc.2019.01.032. Epub 2019 Jan 28.

PMID:
30712980
10.

The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.

Naruse G, Kanamori H, Yoshida A, Minatoguchi S, Kawaguchi T, Iwasa M, Yamada Y, Mikami A, Kawasaki M, Nishigaki K, Minatoguchi S.

Cardiovasc Res. 2019 Nov 1;115(13):1873-1885. doi: 10.1093/cvr/cvz002.

PMID:
30629149
11.

In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.

Chávez-Fumagalli MA, Lage DP, Tavares GSV, Mendonça DVC, Dias DS, Ribeiro PAF, Ludolf F, Costa LE, Coelho VTS, Coelho EAF.

J Mol Graph Model. 2019 Mar;87:89-97. doi: 10.1016/j.jmgm.2018.11.014. Epub 2018 Nov 29.

PMID:
30522092
12.

Enhanced Production of 6-(N-Hydroxyethyl)-Amino-6-Deoxy-α-L-Sorbofuranose by Immobilized Gluconobacter oxydanson Corn Stover with a pH Control Strategy in a Bubble Column Bioreactor.

Hu ZC, Bu JL, Wang RY, Ke X, Zheng YG.

Appl Biochem Biotechnol. 2019 Jun;188(2):297-309. doi: 10.1007/s12010-018-2924-y. Epub 2018 Nov 15.

PMID:
30430346
13.

Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway.

Lee EY, Zhang X, Miyamoto J, Kimura I, Taknaka T, Furusawa K, Jomori T, Fujimoto K, Uematsu S, Miki T.

J Endocrinol. 2018 Dec 1;239(3):267-276. doi: 10.1530/JOE-18-0241.

PMID:
30400014
14.

Divergent synthesis of new α-glucosidase inhibitors obtained through a vinyl Grignard-mediated carbocyclisation.

Knudsen IMB, Hedberg C, Ladefoged LK, Ide D, Brinkø A, Eikeland EZ, Kato A, Jensen HH.

Org Biomol Chem. 2018 Aug 29;16(34):6250-6261. doi: 10.1039/c8ob01433g.

PMID:
30110037
15.

Iminosugars Spiro-Linked with Morpholine-Fused 1,2,3-Triazole: Synthesis, Conformational Analysis, Glycosidase Inhibitory Activity, Antifungal Assay, and Docking Studies.

Chavan SR, Gavale KS, Khan A, Joshi R, Kumbhar N, Chakravarty D, Dhavale DD.

ACS Omega. 2017 Oct 31;2(10):7203-7218. doi: 10.1021/acsomega.7b01299. Epub 2017 Oct 26.

16.

Miglitol.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

17.

Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.

Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E.

Hepatol Res. 2018 Dec;48(13):1092-1098. doi: 10.1111/hepr.13223. Epub 2018 Jul 27.

PMID:
29935004
18.

Characterization of α-Glucosidase Inhibitor/Cyclodextrin Complex Prepared by Freeze-Drying.

Inoue Y, Narumi S, Mitsumori A, Murata I, Kanamoto I.

J Pharm (Cairo). 2018 May 7;2018:3202719. doi: 10.1155/2018/3202719. eCollection 2018.

19.

Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase.

Tan K, Tesar C, Wilton R, Jedrzejczak RP, Joachimiak A.

Protein Sci. 2018 Aug;27(8):1498-1508. doi: 10.1002/pro.3444. Epub 2018 Jul 10.

20.

Biosynthesis of miglitol intermediate 6-(N-hydroxyethyl)-amino-6-deoxy-α-l-sorbofuranose by an improved d-sorbitol dehydrogenase from Gluconobacter oxydans.

Ke X, Wang NN, Yu PH, Lu YH, Hu ZC, Zheng YG.

3 Biotech. 2018 May;8(5):231. doi: 10.1007/s13205-018-1251-x. Epub 2018 Apr 28.

Supplemental Content

Loading ...
Support Center